# Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

> **NCT00804219** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 67 (actual)

## Conditions studied

- Tick-borne Encephalitis

## Interventions

- **BIOLOGICAL:** TBE vaccination and influenza vaccination

## Key facts

- **NCT ID:** NCT00804219
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804219, "Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00804219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*